" />


Specialists who take on the challenge of complex trials
Over 12 million new cancer cases were diagnosed in 2007 alone & there were 7.6 million deaths due to cancer. It is beyond doubt that 'cancer' is a daunting challenge and a huge opportunity for the global biopharmaceutical research community.

Even as the number of patients diagnosed explodes, the pipeline of drugs reaching the market is slowing due to ever stringent regulation and increasing costs.

In such a scenario you need a partner with extensive experience who can navigate the complex clinical & regulatory environment & help you bring your drug to market faster.

SIRO's experience and knowledge can make a substantial difference in overcoming the issues you may face while developing new drugs for oncology.

Our competency arises from the fact that we have, in the past, successfully executed around 70 oncology clinical trials globally. We have experience of conducting trials with drug classes like Tyrosine kinase inhibitors, monoclonal antibodies, biosimilars, HER2 inhibitors etc. in complex indications involving long term follow ups, patient diaries and pharmacokinetic sampling. Some of indications in which we have experience are:
  • Non small cell lung cancer/Small Cell lung cancer
  • Metastatic Breast cancer
  • Pancreatic cancer
  • Chronic Lymphatic leukemia
  • Advanced Gastric Cancer
  • Solid Tumor of Hematologic malignancies
  • Advanced multiple myeloma
  • Chemotherapy induced febrile neutropenia

We have an investigator database of more than 290 oncologists which is the mix of medical oncologists, radiation oncologists and hemato-onclogists experienced in conducting studies in various oncology indications. Our sites are distributed across major cities in western and southern India and also include the Regional Cancer Centers (RCC). The RCCs are known for offering modern and comprehensive cancer care in addition to conducting cutting edge research.

Additional Resources
Case Studies:
Oncology case studies